Just had a thought while scrolling through some old investment ideas - there's actually a solid opportunity in publicly traded dental companies that most retail investors completely overlook. A few years back I was sitting in a dentist's chair thinking about how much equipment and products they must source, and it got me curious about which companies actually supply the dental industry. Turns out there's a whole ecosystem of publicly traded dental companies worth paying attention to.

Let me break down seven names that caught my eye. Henry Schein (HSIC) is basically the backbone of the dental supply chain. If you're a dentist, you're probably ordering from them constantly. They distribute over 120,000 branded products plus another 180,000 private label items. The thing is, HSIC was trading pretty cheap a few years ago relative to its history, which seemed like solid value territory given that 90% of U.S. dental practices use them. The company spun off its animal health business and refocused entirely on healthcare, which should help them execute better.

3D Systems (DDD) was interesting because their dental segment was actually performing well despite the broader 3D printing slowdown. They make dentures, crowns, and surgical guides using 3D printing technology. At certain valuations, the stock looked incredibly cheap on a price-to-sales basis. The CEO mentioned there are billions in opportunity since almost anyone could benefit from 3D-printed dental solutions.

Align Technology (ALGN) is the Invisalign company. Yeah, everyone knows about clear aligners now, but back then they were showing massive growth. Revenues were up 34% and they had this whole iTero scanner business growing 68% that people weren't really pricing in. Even with competition from startups offering cheaper alternatives, the core business looked strong.

Dentsply Sirona (XRAY) went through a rough integration after acquiring Sirona, but the turnaround plan they implemented started showing real promise. The company was cutting costs and streamlining operations, and analysts were expecting earnings to hit their best levels since 2016. Sometimes you just need to be patient with these situations.

Patterson Companies (PDCO) was beaten down hard despite having solid cash flow generation. Their operating cash flow was actually accelerating. Yes, earnings were under pressure, but they had diversified revenue streams from both dental and animal health products. Plus they were yielding nearly 5%, so you could get paid while waiting for the business to improve.

Procter & Gamble (PG) owns Oral-B, which is basically the electric toothbrush standard. Their oral care brands were contributing meaningful revenue, and P&G had just raised their dividend for the 63rd consecutive year. Not the most exciting growth story, but incredibly stable.

Church & Dwight (CHD) is smaller than P&G but competes effectively with brands like Arm & Hammer toothpaste, Orajel, and Waterpik. They're actually really good at acquiring smaller brands and scaling them up over time. Over a decade, their stock had delivered nearly double the returns of P&G, which is pretty impressive for a consumer staples company.

The interesting thing about publicly traded dental companies as a group is that they benefit from secular trends - people will always need dental care, products, and equipment. Whether you're looking at the distributors, the equipment makers, or the consumer brands, there's exposure to this growing industry. Worth doing your own research on these, but the dental sector definitely deserves more attention from investors.